Copyright
©The Author(s) 2004.
World J Gastroenterol. Jul 1, 2004; 10(13): 1893-1897
Published online Jul 1, 2004. doi: 10.3748/wjg.v10.i13.1893
Published online Jul 1, 2004. doi: 10.3748/wjg.v10.i13.1893
Sustained response (n = 48) | No sustained response (n = 47) | P value | |
Male, n (%) | 30 (63%) | 29 (62%) | 0.341 |
Age (yr ) | 39 ± 11 | 45 ± 11 | < 0.012 |
ALT | 70 ± 78 | 74 ± 68 | 0.542 |
HCV genotype, n (%) | |||
1 or 4 | 30 (63%) | 37 (79%) | |
2 or 3 | 16 (33%) | 10 (21%) | 0.161 |
Undetermined | 2 (4%) | ||
SEN positive, n (%) | 10 (21%) | 11 (23%) | 0.811 |
SENV H-DNA | 393 ± 297 | 523 ± 452 | 0.482 |
(copies/mL) |
- Citation: Sagir A, Adams O, Kirschberg O, Erhardt A, Heintges T, Häussinger D. SEN virus does not affect treatment response in hepatitis C virus coinfected patients but SEN virus response depends on SEN virus DNA concentration. World J Gastroenterol 2004; 10(13): 1893-1897
- URL: https://www.wjgnet.com/1007-9327/full/v10/i13/1893.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i13.1893